Verition Fund Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
45,319
+38,267
+543% +$8.91M 0.07% 290
2025
Q4
$1.46M Sell
7,052
-28,414
-80% -$5.62M 0.01% 1866
2025
Q3
$6.58M Sell
35,466
-103,514
-74% -$17.7M 0.03% 868
2025
Q2
$21.2M Buy
138,980
+30,663
+28% +$4.71M 0.09% 213
2025
Q1
$18M Sell
108,317
-53,533
-33% -$8.38M 0.08% 257
2024
Q4
$23.4M Buy
161,850
+128,134
+380% +$19.9M 0.09% 189
2024
Q3
$5.46M Sell
33,716
-38,772
-53% -$6.18M 0.03% 797
2024
Q2
$10.6M Sell
72,488
-17,502
-19% -$2.6M 0.06% 328
2024
Q1
$14.2M Sell
89,990
-449,651
-83% -$71.6M 0.1% 197
2023
Q4
$84.6M Buy
539,641
+488,699
+959% +$74.9M 0.66% 11
2023
Q3
$7.93M Sell
50,942
-11,405
-18% -$1.88M 0.09% 282
2023
Q2
$10.3M Buy
62,347
+33,189
+114% +$5.36M 0.14% 196
2023
Q1
$4.52M Sell
29,158
-31,063
-52% -$5.02M 0.06% 405
2022
Q4
$10.6M Sell
60,221
-22,486
-27% -$3.88M 0.17% 142
2022
Q3
$13.5M Buy
82,707
+65,937
+393% +$11.2M 0.15% 146
2022
Q2
$2.98M Sell
16,770
-1,565
-9% -$279K 0.06% 475
2022
Q1
$3.25M Buy
18,335
+9,884
+117% +$1.68M 0.04% 627
2021
Q4
$1.45M Sell
8,451
-8,489
-50% -$1.39M 0.01% 1074
2021
Q3
$2.74M Sell
16,940
-9,190
-35% -$1.57M 0.02% 472
2021
Q2
$4.3M Buy
+26,130
New +$4.33M 0.04% 275
2021
Q1
Sell
-2,914
Closed -$459K 1654
2020
Q4
$459K Buy
+2,914
New +$430K ﹤0.01% 691
2020
Q3
Sell
-13,167
Closed -$1.85M 1230
2020
Q2
$1.85M Sell
13,167
-187,663
-93% -$27.3M 0.06% 237
2020
Q1
$26.3M Buy
200,830
+177,613
+765% +$25.2M 1.04% 23
2019
Q4
$3.39M Buy
23,217
+16,595
+251% +$2.25M 0.06% 195
2019
Q3
$857K Sell
6,622
-16,965
-72% -$2.24M 0.02% 452
2019
Q2
$3.29M Sell
23,587
-11,302
-32% -$1.56M 0.09% 154
2019
Q1
$4.88M Sell
34,889
-608
-2% -$81.4K 0.19% 81
2018
Q4
$4.58M Buy
35,497
+763
+2% +$106K 0.33% 65
2018
Q3
$4.8M Buy
34,734
+8,739
+34% +$1.16M 0.17% 95
2018
Q2
$3.15M Buy
25,995
+19,365
+292% +$2.42M 0.19% 109
2018
Q1
$850K Sell
6,630
-8,650
-57% -$1.17M 0.06% 430
2017
Q4
$2.13M Sell
15,280
-12,108
-44% -$1.69M 0.2% 92
2017
Q3
$3.56M Buy
27,388
+17,792
+185% +$2.36M 0.29% 59
2017
Q2
$1.27M Buy
9,596
+5,308
+124% +$677K 0.12% 146
2017
Q1
$534K Buy
4,288
+1,666
+64% +$199K 0.05% 532
2016
Q4
$302K Sell
2,622
-77
-3% -$8.89K 0.03% 827
2016
Q3
$319K Buy
+2,699
New +$327K 0.03% 751
2016
Q2
Sell
-1,918
Closed -$208K 965
2016
Q1
$208K Sell
1,918
-165
-8% -$17.1K 0.03% 612
2015
Q4
$214K Buy
+2,083
New +$209K 0.04% 375
2015
Q2
Sell
-2,258
Closed -$227K 669
2015
Q1
$227K Buy
2,258
+140
+7% +$14.2K 0.03% 283
2014
Q4
$221K Buy
+2,118
New +$223K 0.05% 216
2014
Q3
Sell
-3,044
Closed -$318K 811
2014
Q2
$318K Buy
3,044
+224
+8% +$22.6K 0.03% 400
2014
Q1
$277K Sell
2,820
-45,097
-94% -$4.18M 0.04% 296
2013
Q4
$4.39M Buy
47,917
+16,453
+52% +$1.52M 0.78% 20
2013
Q3
$2.73M Buy
31,464
+23,347
+288% +$2.09M 0.41% 49
2013
Q2
$697K Buy
+8,117
New +$689K 0.13% 153

Other funds holding JNJ

Verition Fund Management's JNJ Position: Q1 2026 in Review

Verition Fund Management increased its Johnson & Johnson (JNJ) stake by 543% in Q1 2026, buying an estimated $8.91M and bringing the position to 45,319 shares worth $11.1M. The position accounts for 0.07% of the portfolio, ranked #290.

Verition Fund Management first reported a position in JNJ in Q2 2013 and has held it in 46 quarters since. The position peaked at $84.6M in Q4 2023. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Verition Fund Management held 45,319 shares of Johnson & Johnson worth $11.1M as of Q1 2026.
  • Verition Fund Management bought 38,267 Johnson & Johnson shares in Q1 2026, an estimated $8.91M.
  • Johnson & Johnson made up 0.07% of Verition Fund Management's portfolio in Q1 2026, its #290 holding.
  • Verition Fund Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 46 quarters since.
  • Verition Fund Management's Johnson & Johnson position peaked at $84.6M in Q4 2023.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.